Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Her is my answer from Hawk on the Royalty payment question

IMO the runs to .94 were largely due to the anticipation of a windfall of cash coming into PTSC for the settlement with the J's regardless of the USPTO review. $100's of millions of dollars would move the SP regardless.

All the best,

Steve

Share
New Message
Please login to post a reply